✦ LIBER ✦

Scaleup of Immediate Release Oral Solid Dosage Forms

✍ Scribed by J. P. Skelly; G. A. Van Buskirk; D. R. Savello; G. L. Amidon; H. M. Arbit; S. Dighe; M. B. Fawzi; M. A. Gonzalez; A. W. Malick; H. Malinowski; R. Nedich; G. E. Peck; D. M. Pearce; V. Shah; R. F. Shangraw; J. B. Schwartz; J. Truelove

Book ID: 110379457
Publisher: Springer US
Year: 1993
Tongue: English
Weight: 803 KB
Volume: 10
Category: Article
ISSN: 0724-8741
DOI: 10.1023/a:1018915700942

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immediate drug release from solid oral d

Immediate drug release from solid oral dosage forms

✍ Thomas Schreiner; Ulrich F. Schaefer; Helmut Loth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

Fast drug release from solid dosage forms requires a very fast contact of the vast majority of the drug particles with the solvent; this, however, is particularly delayed in tablets and granulations. Starch and cellulose substances favor the matrix disintegration during the starting phase and the ge

Biowaiver monographs for immediate-relea

Biowaiver monographs for immediate-release solid oral dosage forms: Ketoprofen

✍ Igor E. Shohin; Julia I. Kulinich; Galina V. Ramenskaya; Bertil Abrahamsson; Sab 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Biowaiver monographs for immediate relea

Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin

✍ C. Becker; J.B. Dressman; H.E. Junginger; S. Kopp; K.K. Midha; V.P. Shah; S. Sta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 1 views

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage forms containing rifampicin as the only Active Pharmaceutical Ingredient (API) are reviewed. Rifampicin's so

Biowaiver monographs for immediate relea

Biowaiver monographs for immediate release solid oral dosage forms: Ibuprofen

✍ H. Potthast; J.B. Dressman; H.E. Junginger; K.K. Midha; H. Oeser; V.P. Shah; H. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Literature data are reviewed on the properties of ibuprofen related to the biopharmaceutics classification system (BCS). Ibuprofen was assessed to be a BCS class II drug. Differences in composition and/or manufacturing procedures were reported to have an effect on the rate, but not the extent of abs

Biowaiver monographs for immediate relea

Biowaiver monographs for immediate release solid oral dosage forms: Cimetidine

✍ E. Jantratid; S. Prakongpan; J.B. Dressman; G.L. Amidon; H.E. Junginger; K.K. Mi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

Biowaiver monographs for immediate relea

Biowaiver monographs for immediate release solid oral dosage forms: Isoniazid

✍ C. Becker; J.B. Dressman; G.L. Amidon; H.E. Junginger; S. Kopp; K.K. Midha; V.P. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing isoniazid as the only active pharmaceutical ingredient (API) are reviewed. Isoniazid's solubility and permeability character